Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

New AIDS vaccine candidates reported by Institut Pasteur

Jan. 3, 1997

Immunomodulatory effects of ranitidine assessed in patient studies

Jan. 2, 1997

Expanded use of acellular DTP vaccine approved

Dec. 31, 1996

Connaught describes potential acellular pertussis vaccines

Dec. 24, 1996

Anti-CD2 MAb enters phase II for GVHD

Dec. 23, 1996

Autoimmune disease Rx enters clinical trials

Dec. 20, 1996

Antex to be issued patent covering H. influenzae proteins

Dec. 19, 1996

Positive results reported for group A Streptococcus vaccine

Dec. 18, 1996

Method of producing infectious RSV offered for licensing

Dec. 17, 1996

MedImmune files IND for HPV vaccine candidate

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.